Process development and scale-up of recombinant protein vaccines
M11
Course Goals
Process development and scale-up of recombinant protein vaccines.
Course content
A list of the course contents is given on the General strategies in process development for recombinant protein production and purification in different host systems with a special focus on state of the art methods to improve down-stream process development by implementing design of experiments and quality by design aspects, e.g. in clarification and chromatographic purification. Typical processes will be discussed using real-life equipment and examples.
Learning Outcomes
Comprehensive insight into the possibilities to conduct and improve process development and scale-up of biomanufacturing processes.
Who should apply
Scientists involved or interested in vaccine R&D and manufacturing projects.
Minimal requirements
Basic understanding of recombinant DNA technology, protein chemistry and typical process unit operations.
Accommodation
Accommodation will be provided. Travel Costs are not included.
Comments
* Due to COVID19 related delays call and training modules' schedule may be subject to change.
Be the first to know about the upcoming application calls, follow European Vaccine Initiative on Twitter and LinkedIn or subscribe to TRANSVAC Newsletter.